On October 19, HEC Group announced on its official WeChat public account that on October 18, the U.S. court officially judged the 405 patent invalid, and the first generic fingolimod Gilenya of Guangdong HEC Pharmaceutical Co., Ltd. was officially approved to be marketed in the United States. Conseq

Approved by the CNIPA, 55 patent pre-examination service classification numbers such as G08G traffic control system and G16B bioinformatics were added by Beijing Intellectual Property Protection Center and Zhongguancun Intellectual Property Protection Center.Till now, the two protection centers have

As of September 2022, the high-value invention patents examination has been reduced to 13 months, the average examination period for invention patents has been reduced to 16.5 months, and the average review cycle for trademark registration remains stable at 4 months. The "telecommunication" of certi

On September 15, the 14th BRICS Heads of Intellectual Property Office Meeting hosted by the State Intellectual Property Office of China was held in the form of video. The meeting was chaired by Shen Changyu, Commissioner of the State Intellectual Property Office of China. Claudio Furtado, Director-G

These days, the CNIPA and the European Patent Office jointly issued a joint communiqué, announcing that the Pilot Project of International Search Authorities under the Patent Cooperation Treaty (PCT) will be extended for one year from December 1, 2022 to November 30, 2023. Under this project, Chines